Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases
Antioxidants · 29.09.2023 · 12 (10) · 1811
DOI: 10.3390/antiox12101811 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 29.09.2023. Verfasst von Izabela Korczowska-Łącka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, 61-701 Poznan, Poland. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 252 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In diseases of the central nervous system, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), stroke, amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), and even epilepsy and migraine, oxidative stress load commonly surpasses endogenous antioxidative capacity. While oxidative processes have been robustly implicated in the pathogenesis of these diseases, the significance of particular antioxidants, both endogenous and especially exogenous, in maintaining redox homeostasis requires further research. Among endogenous antioxidants, enzymes such as catalase, superoxide dismutase, and glutathione peroxidase are central to disabling free radicals, thereby preventing oxidative damage to cellular lipids, proteins, and nucleic acids. Whether supplementation with endogenously occurring antioxidant compounds such as melatonin and glutathione carries any benefit, however, remains equivocal. Similarly, while the health benefits of certain exogenous antioxidants, including ascorbic acid (vitamin C), carotenoids, polyphenols, sulforaphanes, and anthocyanins are commonly touted, their clinical efficacy and effectiveness in particular neurological disease contexts need to be more robustly defined. Here, we review the current literature on the cellular mechanisms mitigating oxidative stress and comment on the possible benefit of the most common exogenous antioxidants in diseases such as AD, PD, ALS, HD, stroke, epilepsy, and migraine. We selected common neurological diseases of a basically neurodegenerative nature.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
- Department of Biochemistry and Molecular Biology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
- Chair and Department of Neurology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
- Department of Psychiatry, Psychotherapy and Early Intervention, Medical University of Lublin, 20-059 Lublin, Poland.
ORCID-Profile: Izabela Korczowska-Łącka, Oliwia Szymanowicz, Paweł P Jagodziński, Jolanta Dorszewska
Zitieren
APA
Korczowska-Łącka, I., Słowikowski, B., Piekut, T., Hurła, M., Banaszek, N., Szymanowicz, O., Jagodziński, P. P., Kozubski, W., Permoda-Pachuta, A., & Dorszewska, J. (2023). Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases. Antioxidants, 12(10), 1811. https://doi.org/10.3390/antiox12101811
Vancouver
Korczowska-Łącka I, Słowikowski B, Piekut T, Hurła M, Banaszek N, Szymanowicz O, et al. Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases. Antioxidants. 2023;12(10):1811. doi:10.3390/antiox12101811
BibTeX
@article{Korczowskacka2023,
author = {Korczowska-Łącka, Izabela and Słowikowski, Bartosz and Piekut, Thomas and Hurła, Mikołaj and Banaszek, Natalia and Szymanowicz, Oliwia and Jagodziński, Paweł P and Kozubski, Wojciech and Permoda-Pachuta, Agnieszka and Dorszewska, Jolanta},
title = {Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {10},
pages = {1811},
doi = {10.3390/antiox12101811}
}
EUVIMED